Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.
about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesTherapeutic cancer vaccines: using unique antigensDysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic AgentsAdvances of immunotherapy in small cell lung cancerProtein modifications as potential biomarkers in breast cancer.Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.A strategy for the selective imaging of glycans using caged metabolic precursors.Driving CAR T-cells forwardOn the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.Androgen-regulated transcriptional control of sialyltransferases in prostate cancer cellsImmunotherapeutic Intervention against Sarcomas.Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen.A practical total synthesis of globo-H for use in anticancer vaccines.Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancerImmunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trialCHoMP: a chemoenzymatic histology method using clickable probes.Reassessing target antigens for adoptive T-cell therapy.Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivoPolyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.The case for polyvalent cancer vaccines that induce antibodies.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive SystemComparison of GD2 binding capture ELISA assays for anti-GD2-antibodies using GD2-coated plates and a GD2-expressing cell-based ELISACancer vaccines and carbohydrate epitopes.A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomasAlkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.Cellular immuno-PCR. Detection of a carbohydrate tumor marker.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Human Cancer Antigen Globo H Is a Cell-Surface Ligand for Human Ribonuclease 1.Novel therapeutic approaches for small cell lung cancer: the future has arrivedCarbohydrate vaccines as immunotherapy for cancer.Immunotherapy of cancer in 2012.Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray.Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.
P2860
Q21129299-5EC8EA78-52C0-4A58-A2C3-F61313ECF2C8Q24563772-C8E5BA4C-3A5B-4A5B-8D3B-FC9F0F606433Q26771367-C6821D64-5C5E-475E-A622-007BED88317FQ27027662-09B0E10E-1532-41F7-933E-377E4553A2E9Q33586407-0353234F-A249-49B0-9050-EABE3BDC2F55Q33597441-3AF1757D-DF4C-48B8-B469-DE2E62AFC415Q33739686-AD6A6D67-2AF8-4221-A605-A077E4489057Q33899683-39C393A5-2748-405C-96F5-4462058A1E70Q33932479-AC1778CD-8140-418B-900E-F2C2E8A37787Q33997622-87CA1565-C65F-4E27-AD90-0AEDA2CE223AQ34010347-239D2FA3-865B-4DE0-BF57-27667F1743FAQ34046505-45414C4A-6BCB-4920-9BBE-95711C82FF0EQ34160588-2A2EF1A9-F221-4530-A6A6-763689B5CD37Q34162748-86308EDD-2EC5-4E51-ABB6-E3E70965B3EDQ34196481-321CD370-9BA0-4754-BAA2-5A762B9ACD08Q34248323-6F11D279-DE41-4A50-9F8D-457B8AAA04CBQ34470586-42E8CF02-EEAE-4B1B-BB61-F86381C736B2Q34565029-9809E079-669D-4D07-BA08-5303D8F7C5A0Q34720308-0D7B7038-8EB9-4287-8C4D-9FB07D726B8CQ34785017-CF0248B1-AA6C-4E4A-A103-4D7C9275E6AFQ34789569-C7370EB8-CA66-492D-92F1-1A41D6A4AA77Q34884062-0E4C037F-9F16-4936-B557-BD4E3A0334CDQ35033695-78F8F867-C05A-4EDD-90A7-B9BECACD77AAQ35079733-A3E05C22-30D4-42E3-B66C-8E990CEBDA3AQ35193433-9C9F7E8B-DCFE-4B8F-B3C6-66734CEC35B2Q35200716-C0754D98-E248-4966-845B-E23143CFC5C0Q35381031-0D24FA18-5639-4A59-B128-262D8888478AQ35525289-58FB3D73-DA32-4C5D-B6F3-9520A783DC25Q35632469-EB03ED9D-B209-45F3-8D45-BB8FD47B6428Q35669639-81DF7C78-35D1-4B1C-BDFE-7D5E6100F005Q35684309-922FE840-D69F-42B3-A6BA-B2BF5184D64CQ35765166-AB616BD2-DE9F-4E27-917C-0B450861CE9EQ35854131-F14D32D5-E0E3-4F9A-AF5F-17F0F8BDFBA8Q36063340-03BAF8FA-9DC6-4ACA-B815-3E08E411F96DQ36084288-106B5DA8-8C65-43C0-AB92-667D8E39F3D1Q36201691-33F6577D-DFBB-464B-B36F-9B43E74BF225Q36243536-74E147C2-E587-419A-A402-D8F293C8C018Q36278684-7C5E41CC-7852-48B8-9A43-FB0AB109FC6AQ36284550-6AC8D561-B61A-4331-BEEA-310142A18417Q36366425-475451FA-1371-4A5C-B8B4-66D8A6566F86
P2860
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@en
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@nl
type
label
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@en
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@nl
prefLabel
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@en
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@nl
P2093
P2860
P1476
Selection of tumor antigens as ...... try: I. Focus on gangliosides.
@en
P2093
C Cordon-Cardo
P O Livingston
V E Reuter
W B Hamilton
P2860
P356
10.1002/(SICI)1097-0215(19970926)73:1<42::AID-IJC8>3.0.CO;2-1
P577
1997-09-01T00:00:00Z